Is Rigetti Stock a Buy or Hold After Its Q2 Earnings Report?
Rigetti Computing (RGTI) reported Q2 2026 revenue up 185% year over year to $5.1 million, driven by on-premises Novera QPU sales. The company cited progress on its 108-qubit Cepheus-1 system and partnerships with HPE and the Pittsburgh Supercomputing Center. It also said it could receive up to $100 million from the U.S. Department of Commerce, not yet finalized, while Q2 operating expenses rose to $30.3 million and it posted an operating loss of $28.1 million.
How this was made
The 30-second read
Why it matters
Traders can reassess near-term expectations around commercialization milestones (Cepheus-1 progress, cloud/on-prem availability) and the probability/timing of the potential Commerce award, while monitoring cash burn and delivery cadence.
Market read
Provides specific Q2 financial and technical metrics plus forward-looking commercialization and funding items, which can shift short-term positioning in quantum-computing names.
What to watch
The Commerce funding is only “selected” and “not finalized,” and the article flags revenue dependence on large system deliveries, which can amplify quarter-to-quarter volatility.
Background
The piece frames Rigetti’s Q2 2026 results as a test of whether technical progress and early commercial traction can offset ongoing operating losses and uneven revenue timing.
Ticker impact
Rigetti reported Q2 2026 results with revenues up 185% to $5.1M, plus progress on its 108-qubit Cepheus-1 and potential $100M Commerce funding.
Near-term trading likely two-sided: upside on revenue growth and milestone progress, downside if investors focus on continued operating losses and uneven commercialization.
The article provides concrete Q2 datapoints (revenue, operating expenses, adjusted net loss) and specific forward-looking items (Cepheus-1 availability, expected C-DAC revenue recognition, potential Commerce award not finalized). That combination typically drives volatility rather than a clean directional move.
Market effects
Reinforces the sector’s core debate: commercialization timing versus technical progress, with investors comparing Rigetti against IonQ, D-Wave, and QUBT.
US-focused government support narrative (Commerce selection) may marginally improve sentiment toward US quantum R&D beneficiaries.
Limited direct global read-through beyond investor appetite for superconducting quantum scaling stories.
Counterpoint
The revenue surge may be delivery-driven and not yet indicative of durable commercial demand, while losses and capex needs could dilute shareholders before meaningful profitability.
Key entities
- companyRigetti Computing
Subject of the article, reporting Q2 2026 results and progress on its Cepheus-1 and roadmap targets.
- governmentU.S. Department of Commerce
Selected Rigetti for a potential award of up to $100M over three years, pending finalization.
- companyHPE
Partnered with Rigetti on a 9-qubit Novera deployment in an HPE-powered supercomputing environment.
- research_institutionPittsburgh Supercomputing Center
Collaborator on the hybrid quantum-classical workload project with Rigetti and HPE.
